Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Crataegus (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
Most Recent Events
- 07 Feb 2013 Biomarkers information updated
- 12 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Apr 2011 Planned number of patients changed from 24 to NULL.